当前位置:
X-MOL 学术
›
Nat. Rev. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Dissecting the benefits of sacubitril-valsartan for heart failure.
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2020-02-01 , DOI: 10.1038/s41569-019-0322-y Irene Fernández-Ruiz 1
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2020-02-01 , DOI: 10.1038/s41569-019-0322-y Irene Fernández-Ruiz 1
Affiliation
New analyses of the PARAGON-HF and PARADIGM-HF trials indicate that sacubitril–valsartan treatment might be beneficial in patients with heart failure with mildly reduced left ventricular ejection fraction and that the benefit might be greater in women than in men.
中文翻译:
剖析沙库巴曲缬沙坦对心力衰竭的益处。
对 PARAGON-HF 和 PARADIGM-HF 试验的新分析表明,沙库巴曲缬沙坦治疗可能对左心室射血分数轻度降低的心力衰竭患者有益,并且女性的益处可能大于男性。
更新日期:2019-12-03
中文翻译:
剖析沙库巴曲缬沙坦对心力衰竭的益处。
对 PARAGON-HF 和 PARADIGM-HF 试验的新分析表明,沙库巴曲缬沙坦治疗可能对左心室射血分数轻度降低的心力衰竭患者有益,并且女性的益处可能大于男性。